Stock Events

Mankind Pharma 

₹2,682.95
20
-₹33.05-1.22% Thursday 10:00

Estadísticas

Día Alto
-
Día de baja
-
52W Alto
-
52W Bajo
-
Volumen
-
Volumen medio
-
Cap. de mercado
1.09T
Relación P/U
55.45
Rentabilidad por dividendo
-
Dividendo
-

Próximamente

Ganancias

29OctEsperado
Q2 2023
Q4 2023
Q1 2024
Q2 2024
Siguiente
9.62
11.11
12.6
14.09
GPA esperado
No aplica
GPA actual
No aplica

La gente también sigue a

Esta lista se basa en las watchlists de personas que siguen a MANKIND.NSE en Stock Events. Esto no es una recomendación de inversión.

Competidores

Esta lista es un análisis basado en eventos recientes del mercado. No es una recomendación de inversión.

Acerca de

Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products primarily in India and internationally. The company develops pharmaceuticals for acute and chronic therapeutics in the areas of anti-infective, cardiovascular, gastrointestinal, anti-diabetic, dermatology, pain/analgesics, neuro/CNS, vitamins/minerals/nutrients, and respiratory diseases. It also provides consumer healthcare products, such as condoms, pregnancy detection kits, emergency contraceptives, antacid powders, vitamin and mineral supplements, and anti-acne preparations. The company offers its products primarily under the Manforce, Prega News, Unwanted-72, Gas-O-Fas, Health OK, and AcneStar brand names. In addition, it engages in the trading and exporting of pharmaceutical and health care products; manufacturing of packing materials ayurvedic products, packing materials, bulk drugs, and consumer goods; real estate, leasing, and hospitality businesses; and provision of IT services. Mankind Pharma Limited was founded in 1986 and is based in New Delhi, India.
Show more...
Director general
Mr. Ramesh C. Juneja
Empleados
19540
País
IN
ISIN
INE634S01028

Listados